Corning Inc. announced this week it will make available green-laser prototypes to potential projection module customers for evaluation throughout 2007. The company said it reached the decision after integrating a green-laser prototype small enough for use in mobile consumer electronics into a functioning integrated photonics module (IPM), which is being demonstrated by Microvision this week at the Consumer Electronics Show (CES) in Las Vegas. Corning said its green laser enables full-motion color video images at SVGA resolution. “With the rapid growth and diversity of mobile, handheld electronic devices, there is an exciting opportunity for compact projection technology to enable entirely new viewing experiences,” said David Charlton, vice president and director, New Business Development at Corning Science and Technology. “We are very pleased with the results achieved in applying Corning’s extensive experience in high-power lasers and optical physics to the development of this critical component enabling projection technology.” Also this week, Corning became one of six founding members of the LCD TV (Liquid Crystal Display Television) Association, a new nonprofit trade association that announced its formation at CES. Other members are DisplaySearch, LG.Philips LCD, Micronas Semiconductor, Syntax-Brillian Corp. and the US Display Consortium (USDC). The organization said it aims to "promote the entire LCD TV industry and its members' interests and to lead the companies in addressing industrywide issues and new initiatives that will foster healthy competition and create better products for manufacturers, consumers and retailers alike." Corning recently announced the opening of Epic Applications Centers in Big Flats, N.Y., and Fontainebleau, France, to provide product demonstrations and support services to Corning Epic system customers. The Epic system is a label-free screening platform based on optical biosensor technology. It performs biochemical and cell-based drug discovery applications and offers drug dhas evelopers the ability to evaluate promising new drug targets. It uses optical technology to eliminate the need for labels and consists of two basic components: a disposable 384-well microplate with integrated biosensors and a high-throughput screening (HTS)-compatible microplate reader. For more information, visit: corning.com